Annual ROE
-59.90%
-2.75%-4.81%
December 31, 2022
Summary
- As of February 9, 2025, SURF annual return on equity is -59.90%, with the most recent change of -2.75% (-4.81%) on December 31, 2022.
- During the last 3 years, SURF annual ROE has risen by +8.79% (+12.80%).
Performance
SURF ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly ROE
-111.71%
-23.89%-27.20%
June 30, 2023
Summary
- As of February 9, 2025, SURF quarterly return on equity is -111.71%, with the most recent change of -23.89% (-27.20%) on June 30, 2023.
- Over the past year, SURF quarterly ROE has dropped by -63.54% (-131.91%).
Performance
SURF Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
SURF ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.8% | -131.9% |
| 3 y3 years | +12.8% | -246.8% |
| 5 y5 years | -124.8% | +15.4% |
SURF ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | +4.8% | at low | +177.3% | at low |
| 5 y | 5-year | -207.2% | +14.7% | -279.9% | at low |
| alltime | all time | -124.8% | +35.1% | -146.3% | +18.2% |
Surface Oncology ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | -111.71%(+27.2%) |
| Mar 2023 | - | -87.82%(+65.4%) |
| Dec 2022 | -59.90%(+4.8%) | -53.11%(+1.0%) |
| Sep 2022 | - | -52.58%(+9.2%) |
| Jun 2022 | - | -48.17%(+19.6%) |
| Mar 2022 | - | -40.28%(-26.8%) |
| Dec 2021 | -57.15%(-202.3%) | -55.04%(-680.0%) |
| Sep 2021 | - | 9.49%(-27.9%) |
| Jun 2021 | - | 13.17%(-28.0%) |
| Mar 2021 | - | 18.28%(-70.6%) |
| Dec 2020 | 55.87% | 62.11%(-302.6%) |
| Sep 2020 | - | -30.65%(-4.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | -32.21%(-9.9%) |
| Mar 2020 | - | -35.75%(-46.1%) |
| Dec 2019 | -68.69%(+85.0%) | -66.29%(+40.8%) |
| Sep 2019 | - | -47.09%(+10.6%) |
| Jun 2019 | - | -42.59%(-16.8%) |
| Mar 2019 | - | -51.20%(+276.5%) |
| Dec 2018 | -37.12%(-115.4%) | -13.60%(-73.1%) |
| Sep 2018 | - | -50.50%(-61.8%) |
| Jun 2018 | - | -132.04%(+4.3%) |
| Mar 2018 | - | -126.58%(-152.4%) |
| Dec 2017 | 241.41%(-398.3%) | 241.41% |
| Dec 2016 | -80.93% | - |
FAQ
- What is Surface Oncology annual return on equity?
- What is the all time high annual ROE for Surface Oncology?
- What is Surface Oncology annual ROE year-on-year change?
- What is Surface Oncology quarterly return on equity?
- What is the all time high quarterly ROE for Surface Oncology?
- What is Surface Oncology quarterly ROE year-on-year change?
What is Surface Oncology annual return on equity?
The current annual ROE of SURF is -59.90%
What is the all time high annual ROE for Surface Oncology?
Surface Oncology all-time high annual return on equity is 241.41%
What is Surface Oncology annual ROE year-on-year change?
Over the past year, SURF annual return on equity has changed by -2.75% (-4.81%)
What is Surface Oncology quarterly return on equity?
The current quarterly ROE of SURF is -111.71%
What is the all time high quarterly ROE for Surface Oncology?
Surface Oncology all-time high quarterly return on equity is 241.41%
What is Surface Oncology quarterly ROE year-on-year change?
Over the past year, SURF quarterly return on equity has changed by -63.54% (-131.91%)